Lilith Hayakawa Mist
Executive Clinical Research Director, Global Clinical Trial Operations-North America, Merck
Lilith Hayakawa Mist is an innovative leader who has dedicated her professional life to excellence in the conduct of clinical trials. After over 20 years delivering complex projects in a wide range of therapeutic areas, she’s excited by the transformational potential of this time in the industry, when research professionals everywhere are asking themselves and each other, “How can we be more equitable and patient-centered? How can we innovate to reduce burden to sites and patients? What efficiencies and insights are going allow us to bring life-saving medicines to those who need them?” As Executive Director, Global Clinical Trial Operations, she oversees US ID & Vaccine trial operations for Merck.